Concerns Raised About COVID-19 Chronic Olfactory Dysfunction
Research needed on how to treat olfactory dysfunction lasting six months or longer as a symptom of long-term COVID-19
Caregivers More Likely to Have Subjective Cognitive Decline
Caregivers with SCD more likely than caregivers without SCD to report frequent mental distress, history of depression
Access to Care Disrupted for Young Adults With Diabetes in COVID-19
Young adults with diabetes also report lower intention of receiving COVID-19 vaccination compared with those 60 years or older
ICU Bed Occupancy During COVID-19 Linked to Increase in Excess Deaths
If ICU bed use reached 75 percent capacity nationwide, an excess of 12,000 deaths would be expected two weeks later
Ethical Considerations Explored for Aducanumab in Alzheimer Disease
Grounds insufficient to offer aducanumab for moderate, advanced Alzheimer dementia or patients without biomarker evidence of brain ß-amyloid
AHA: Risk for Heart Disease Up for Young Black Adults in the U.S.
Comparison of cohorts of hospitalized young, Black adults from 2007 and 2017 shows higher rates of risk factors for CVD
Patients Hospitalized With COVID-19 Less Likely to Be Vaccinated
Decreased likelihood of vaccination also seen in association with death, mechanical ventilation among patients hospitalized with COVID-19
AHA: Risk-Benefit of Mitral Valve Surgery Plus Tricuspid Annuloplasty Studied
For mitral valve surgery plus TA, risk for primary end-point event lower at two years, but risk for permanent pacemaker implantation higher
Moderna Asks FDA to Approve Its Booster Shot for All Adults
Moderna booster is half the dose of the initial vaccination series: 50 mcg versus 100 mcg
